| Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death R Na, SL Zheng, M Han, H Yu, D Jiang, S Shah, CM Ewing, L Zhang, ... European urology 71 (5), 740-747, 2017 | 365 | 2017 |
| Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31. 2 and 19q13. 4 J Xu, Z Mo, D Ye, M Wang, F Liu, G Jin, C Xu, X Wang, Q Shao, Z Chen, ... Nature genetics 44 (11), 1231-1235, 2012 | 195 | 2012 |
| Germline mutations in ATM and BRCA1/2 are associated with grade reclassification in men on active surveillance for prostate cancer HB Carter, B Helfand, M Mamawala, Y Wu, P Landis, H Yu, K Wiley, R Na, ... European urology 75 (5), 743-749, 2019 | 182 | 2019 |
| A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men X Lin, L Qu, Z Chen, C Xu, D Ye, Q Shao, X Wang, J Qi, Z Chen, F Zhou, ... The Prostate 73 (2), 169-175, 2013 | 96 | 2013 |
| A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer Y Wu, H Yu, SL Zheng, R Na, M Mamawala, T Landis, K Wiley, ... The Prostate 78 (8), 607-615, 2018 | 73 | 2018 |
| Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer M Wang, A Takahashi, F Liu, D Ye, Q Ding, C Qin, C Yin, Z Zhang, ... Nature communications 6, 2015 | 69 | 2015 |
| Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9 H Jiang, L Zhang, J Liu, Z Chen, R Na, G Ding, H Zhang, Q Ding Cancer gene therapy 19 (10), 684-689, 2012 | 49 | 2012 |
| Rare germline pathogenic mutations of DNA repair genes are most strongly associated with grade group 5 prostate cancer Y Wu, H Yu, S Li, K Wiley, SL Zheng, H LaDuca, M Gielzak, R Na, ... European urology oncology 3 (2), 224-230, 2020 | 48 | 2020 |
| Performance of serum prostate‐specific antigen isoform [‐2] proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital‐based biopsy population R Na, D Ye, F Liu, H Chen, J Qi, Y Wu, G Zhang, M Wang, W Wang, J Sun, ... The Prostate 74 (15), 1569-1575, 2014 | 46 | 2014 |
| The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population S Liu, J Hou, H Zhang, Y Wu, M Hu, L Zhang, J Xu, R Na, H Jiang, Q Ding PloS one 10 (4), e0123617, 2015 | 43 | 2015 |
| Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer CA Conran, R Na, H Chen, D Jiang, X Lin, SL Zheng, CB Brendler, J Xu Asian journal of andrology 18 (4), 520-524, 2016 | 42 | 2016 |
| Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk‐associated SNPs H Jiang, F Liu, Z Wang, R Na, L Zhang, Y Wu, J Zheng, X Lin, D Jiang, ... The Prostate 73 (15), 1651-1659, 2013 | 42 | 2013 |
| The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients S Liu, T Yang, R Na, M Hu, L Zhang, Y Fu, H Jiang, Q Ding International urology and nephrology 47 (6), 951-958, 2015 | 41 | 2015 |
| A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) R Na, BT Helfand, H Chen, CA Conran, SE Crawford, SW Hayward, ... The Prostate 77 (11), 1213-1220, 2017 | 39 | 2017 |
| Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis Z Shi, EA Platz, J Wei, R Na, RJ Fantus, CH Wang, SE Eggener, PJ Hulick, ... European Urology 79 (3), 419-426, 2021 | 38 | 2021 |
| Plateau effect of prostate cancer risk‐associated SNPs in discriminating prostate biopsy outcomes S Ren, J Xu, T Zhou, H Jiang, H Chen, F Liu, R Na, L Zhang, Y Wu, J Sun, ... The prostate 73 (16), 1824-1835, 2013 | 38 | 2013 |
| Plasma genistein and risk of prostate cancer in Chinese population Y Wu, L Zhang, R Na, J Xu, Z Xiong, N Zhang, W Dai, H Jiang, Q Ding International urology and nephrology 47 (6), 965-970, 2015 | 36 | 2015 |
| HOXA9, PCDH17, POU4F2, and ONECUT2 as a urinary biomarker combination for the detection of bladder cancer in Chinese patients with hematuria Y Wu, G Jiang, N Zhang, S Liu, X Lin, C Perschon, SL Zheng, Q Ding, ... European urology focus 6 (2), 284-291, 2020 | 35 | 2020 |
| Combination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition G Ding, C Feng, H Jiang, Q Ding, L Zhang, R Na, H Xu, J Liu PloS one 8 (10), e77400, 2013 | 35 | 2013 |
| Evaluation of reported prostate cancer risk‐associated SNPs from genome‐wide association studies of various racial populations in Chinese men R Na, F Liu, P Zhang, D Ye, C Xu, Q Shao, J Qi, X Wang, Z Chen, M Wang, ... The Prostate 73 (15), 1623-1635, 2013 | 32 | 2013 |
